These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37638035)

  • 21. Nuclear IL-33 Plays an Important Role in the Suppression of FLG, LOR, Keratin 1, and Keratin 10 by IL-4 and IL-13 in Human Keratinocytes.
    Dai X; Utsunomiya R; Shiraishi K; Mori H; Muto J; Murakami M; Sayama K
    J Invest Dermatol; 2021 Nov; 141(11):2646-2655.e6. PubMed ID: 33865911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-mediated Skin Inflammation is Similar in Severe Atopic Dermatitis Patients With or Without Filaggrin Mutation.
    Dajnoki Z; Béke G; Mócsai G; Kapitány A; Gáspár K; Hajdu K; Emri G; Nagy B; Kovács I; Beke L; Dezső B; Szegedi A
    Acta Derm Venereol; 2016 Jun; 96(5):645-50. PubMed ID: 26536977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lipid nutrition and the epidermal barrier: The connection between immune-mediated inflammatory diseases and peroxisome proliferator-activated receptors, a new therapeutic target in psoriasis and atopic dermatitis].
    Villarrubia VG; Vidal-Asensi S; Pérez-Bañasco V; Cuevas-Santos J; Cisterna-Cáncer R
    Actas Dermosifiliogr; 2010 Sep; 101(7):585-99. PubMed ID: 20858385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid Nutrition and the Epidermal Barrier: The Connection Between Immune-Mediated Inflammatory Diseases and Peroxisome Proliferator-Activated Receptors, a New Therapeutic Target in Psoriasis and Atopic Dermatitis.
    Villarrubia VG; Vidal-Asensi S; Pérez-Bañasco V; Cuevas-Santos J; Cisterna-Cáncer R
    Actas Dermosifiliogr; 2010 Sep; 101(7):585-599. PubMed ID: 28709541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor.
    Glatzer F; Gschwandtner M; Ehling S; Rossbach K; Janik K; Klos A; Bäumer W; Kietzmann M; Werfel T; Gutzmer R
    J Allergy Clin Immunol; 2013 Dec; 132(6):1358-67. PubMed ID: 23932072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.
    Lin TK; Man MQ; Santiago JL; Park K; Roelandt T; Oda Y; Hupe M; Crumrine D; Lee HJ; Gschwandtner M; Thyssen JP; Trullas C; Tschachler E; Feingold KR; Elias PM
    J Invest Dermatol; 2013 Feb; 133(2):469-78. PubMed ID: 23014339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation.
    Mitamura Y; Nunomura S; Nanri Y; Ogawa M; Yoshihara T; Masuoka M; Tsuji G; Nakahara T; Hashimoto-Hachiya A; Conway SJ; Furue M; Izuhara K
    Allergy; 2018 Sep; 73(9):1881-1891. PubMed ID: 29528494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.
    Hatano Y; Elias PM; Crumrine D; Feingold KR; Katagiri K; Fujiwara S
    J Invest Dermatol; 2011 Sep; 131(9):1845-52. PubMed ID: 21633371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis.
    Scarponi C; Nardelli B; Lafleur DW; Moore PA; Madonna S; De Pità O; Girolomoni G; Albanesi C
    J Interferon Cytokine Res; 2006 Mar; 26(3):133-40. PubMed ID: 16542135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines.
    Giustizieri ML; Mascia F; Frezzolini A; De Pità O; Chinni LM; Giannetti A; Girolomoni G; Pastore S
    J Allergy Clin Immunol; 2001 May; 107(5):871-7. PubMed ID: 11344355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keratinocytes in inflammatory skin diseases.
    Albanesi C; Scarponi C; Giustizieri ML; Girolomoni G
    Curr Drug Targets Inflamm Allergy; 2005 Jun; 4(3):329-34. PubMed ID: 16101542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of Atopic Dermatitis: Current Paradigm.
    Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
    Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pseudoceramide stimulates peroxisome proliferator-activated receptor-α expression in a murine model of atopic dermatitis: molecular basis underlying the anti-inflammatory effect and the preventive effect against steroid-induced barrier impairment.
    Lee SE; Jung MK; Oh SJ; Jeong SK; Lee SH
    Arch Dermatol Res; 2015 Nov; 307(9):781-92. PubMed ID: 26121942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis.
    Serra-Baldrich E; Santamaría-Babí LF; Francisco Silvestre J
    Actas Dermosifiliogr; 2022; 113(7):674-684. PubMed ID: 35842249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eruca sativa and its flavonoid components, quercetin and isorhamnetin, improve skin barrier function by activation of peroxisome proliferator-activated receptor (PPAR)-α and suppression of inflammatory cytokines.
    Kim B; Choi YE; Kim HS
    Phytother Res; 2014 Sep; 28(9):1359-66. PubMed ID: 24610745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-143 inhibits IL-13-induced dysregulation of the epidermal barrier-related proteins in skin keratinocytes via targeting to IL-13Rα1.
    Zeng YP; Nguyen GH; Jin HZ
    Mol Cell Biochem; 2016 May; 416(1-2):63-70. PubMed ID: 27048505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atopic dermatitis and the stratum corneum: part 1: the role of filaggrin in the stratum corneum barrier and atopic skin.
    Levin J; Friedlander SF; Del Rosso JQ
    J Clin Aesthet Dermatol; 2013 Oct; 6(10):16-22. PubMed ID: 24155988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis.
    Ogawa H; Yoshiike T
    J Dermatol Sci; 1993 Jun; 5(3):197-204. PubMed ID: 8241074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-Activation of Glucocorticoid Receptor and Peroxisome Proliferator-Activated Receptor-γ in Murine Skin Prevents Worsening of Atopic March.
    Deckers J; Bougarne N; Mylka V; Desmet S; Luypaert A; Devos M; Tanghe G; Van Moorleghem J; Vanheerswynghels M; De Cauwer L; Thommis J; Vuylsteke M; Tavernier J; Lambrecht BN; Hammad H; De Bosscher K
    J Invest Dermatol; 2018 Jun; 138(6):1360-1370. PubMed ID: 29288652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.
    Wang Z; Zhang LJ; Guha G; Li S; Kyrylkova K; Kioussi C; Leid M; Ganguli-Indra G; Indra AK
    PLoS One; 2012; 7(12):e51262. PubMed ID: 23284675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.